Document:

Exhibit 10.1

    

     

    

    WARRANT PURCHASE AGREEMENT

    

    

    THIS WARRANT PURCHASE AGREEMENT (as it may from time to time be amended, this “Agreement”), dated as of December 22, 2020, is entered
      into by and among Healthcare Services Acquisition Corporation, a Delaware corporation (the “Company”), and Healthcare Services Acquisition Holdings LLC, a Delaware limited liability company (the “Purchaser”).

    

    

    WHEREAS, the Company intends to consummate an initial public offering of the Company’s units (the “Public Offering”), each unit
      consisting of one share of Class A common stock of the Company, par value $0.0001 per share (each, a “Share”), and one-half of one redeemable warrant, each whole warrant entitling the holder to purchase one
      Share at an exercise price of $11.50 per Share, as set forth in the Company’s Registration Statement on Form S-1, filed with the U.S. Securities and Exchange Commission (the “SEC”), File Number 333-249389 (the
      “Registration Statement”), under the Securities Act of 1933, as amended (the “Securities Act”); and

    

    

    WHEREAS, the Purchaser has agreed to purchase, at a price of $1.00 per warrant, an aggregate of 5,626,000 warrants (and up to 626,400 additional warrants if the underwriter
      in the Public Offering exercises its over-allotment option in full) (the “Private Placement Warrants”), each Private Placement Warrant entitling the holder to purchase one Share at an exercise price of $11.50
      per Share.

    

    

    NOW THEREFORE, in consideration of the mutual promises contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby
      acknowledged, the parties to this Agreement hereby, intending legally to be bound, agree as follows:

    

    

    AGREEMENT

    

    

    Section 1. Authorization, Purchase and Sale; Terms of the Private Placement Warrants.

    

    

    A. Authorization of the Private Placement Warrants. The Company has duly authorized the issuance and sale of the Private Placement Warrants to the
      Purchaser.

    

    

    B. Purchase and Sale of the Private Placement Warrants.

    

    

    (i) On the date of the consummation of the Public Offering (the “IPO Closing Date”), the Company shall issue and
      sell to the Purchaser, and the Purchaser shall purchase from the Company, 5,626,000 Private Placement Warrants at a price of $1.00 per warrant for an aggregate purchase price of $5,626,000.00 (the “Purchase Price”).
      The Purchaser shall pay the Purchase Price by wire transfer of immediately available funds in accordance with the Company’s wiring instructions at least one (1) business day prior to the IPO Closing Date. On the IPO Closing Date, upon the payment by
      the Purchaser of the Purchase Price by wire transfer of immediately available funds to the Company, the Company, at its option, shall deliver a certificate evidencing the Private Placement Warrants purchased on such date duly registered in the
      Purchaser’s name to the Purchaser or effect such delivery in book-entry form.

    

    

    (ii) On the date of the closing of the over-allotment option, if any, in connection with the Public Offering or on such earlier time and date as may be
      mutually agreed by the Purchaser and the Company (each such date, an “Over-allotment Closing Date”, and each Over-allotment Closing Date (if any) and the IPO Closing Date, a “Closing
        Date”), the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the Company, up to 626,400 Private Placement Warrants (or, to the extent the over-allotment option is not exercised in full, a lesser number of
      Private Placement Warrants in proportion to the portion of the over-allotment option that is exercised) at a price of $1.00 per warrant for an aggregate purchase price of up to $626,400.00 (the “Over-allotment
        Purchase Price”). The Purchaser shall pay the Over-allotment Purchase Price by wire transfer of immediately available funds in accordance with the Company’s wiring instructions at least one (1) business day prior to the Over-allotment
      Closing Date. On the Over-allotment Closing Date, upon the payment by the Purchaser of the Over-allotment Purchase Price by wire transfer of immediately available funds to the Company, the Company, at its option, shall deliver a certificate
      evidencing the Private Placement Warrants purchased on such date duly registered in the Purchaser’s name to the Purchaser or effect such delivery in book-entry form.

    

    

    
      

      
        

      

    

    C. Terms of the Private Placement Warrants.

    

    

    (i) Each Private Placement Warrant shall have the terms set forth in a Warrant Agreement to be entered into by the Company and a warrant agent, in
      connection with the Public Offering (the “Warrant Agreement”), and shall be subject to the terms of a letter agreement to be entered into by the Company, the Purchaser and the other parties thereto, in
      connection with the Public Offering.

    

    

    (ii) At the time of, or prior to, the IPO Closing Date, the Company and the Purchaser shall enter into a registration and stockholder rights agreement (the
      “Registration and Stockholder Rights Agreement”) pursuant to which the Company will grant certain registration rights to the Purchaser relating to the Private Placement Warrants and the Shares underlying the
      Private Placement Warrants.

    

    

    Section 2. Representations and Warranties of the Company.

    

    

    As a material inducement to the Purchaser to enter into this Agreement and purchase the Private Placement Warrants, the Company hereby represents and warrants to the
      Purchaser (which representations and warranties shall survive each Closing Date) that:

    

    

    A. Incorporation and Corporate Power. The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the
      State of Delaware and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably be expected to have a material adverse effect on the financial condition, operating results or assets of the Company. The
      Company possesses all requisite corporate power and authority necessary to carry out the transactions contemplated by this Agreement and the Warrant Agreement.

    

    

    B. Authorization; No Breach.

    

    

    (i) The execution, delivery and performance of this Agreement and the Private Placement Warrants have been duly authorized by the Company as of each
      Closing Date. This Agreement constitutes the valid and binding obligation of the Company, enforceable in accordance with its terms, subject to bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general
      applicability relating to or affecting creditors’ rights and to general equitable principles (whether considered in a proceeding in equity or law). Upon issuance in accordance with, and payment pursuant to, the terms of the Warrant Agreement and this
      Agreement, the Private Placement Warrants will constitute valid and binding obligations of the Company, enforceable in accordance with their terms as of each Closing Date.

    

    

    (ii) The execution and delivery by the Company of this Agreement and the Private Placement Warrants, the issuance and sale of the Private Placement
      Warrants, the issuance of the Shares upon exercise of the Private Placement Warrants and the fulfillment of and compliance with the respective terms hereof and thereof by the Company, do not and will not as of each Closing Date (a) conflict with or
      result in a breach of the terms, conditions or provisions of, (b) constitute a default under, (c) result in the creation of any lien, security interest, charge or encumbrance upon the Company’s capital stock or assets under, (d) result in a violation
      of, or (e) require any authorization, consent, approval, exemption or other action by or notice or declaration to, or filing with, any court or administrative or governmental body or agency pursuant to the certificate of incorporation or the bylaws
      of the Company (in effect on the date hereof or as may be amended prior to completion of the Public Offering) or any material law, statute, rule or regulation to which the Company is subject, or any agreement, order, judgment or decree to which the
      Company is subject, except for any filings required after the date hereof under federal or state securities laws.

    

    

    
      

      
        

      

    

    C. Title to Securities. Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, the Shares issuable
      upon exercise of the Private Placement Warrants will be duly and validly issued, fully paid and nonassessable. Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, the Purchaser will have good title
      to the Private Placement Warrants purchased by it and the Shares issuable upon exercise of such Private Placement Warrants, free and clear of all liens, claims and encumbrances of any kind, other than (i) transfer restrictions hereunder and under the
      other agreements contemplated hereby, (ii) transfer restrictions under federal and state securities laws, and (iii) liens, claims or encumbrances imposed due to the actions of the Purchaser.

    

    

    D. Governmental Consents. No permit, consent, approval or authorization of, or declaration to or filing with, any governmental authority is
      required in connection with the execution, delivery and performance by the Company of this Agreement or the consummation by the Company of any other transactions contemplated hereby.

    

    

    E. Regulation D Qualification. Neither the Company nor, to its actual knowledge, any of its affiliates, members, officers, directors or beneficial
      shareholders of 20% or more of its outstanding securities, has experienced a disqualifying event as enumerated pursuant to Rule 506(d) of Regulation D under the Securities Act.

    

    

    Section 3. Representations and Warranties of the Purchaser.

    

    

    As a material inducement to the Company to enter into this Agreement and issue and sell the Private Placement Warrants to the Purchaser, the Purchaser hereby represents and
      warrants to the Company (which representations and warranties shall survive each Closing Date) that:

    

    

    A. Organization and Requisite Authority. The Purchaser possesses all requisite power and authority necessary to carry out the transactions
      contemplated by this Agreement.

    

    

    B. Authorization; No Breach.

    

    

    (i) This Agreement constitutes a valid and binding obligation of the Purchaser, enforceable in accordance with its terms, subject to bankruptcy,
      insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors’ rights and to general equitable principles (whether considered in a proceeding in equity or law).

    

    

    (ii) The execution and delivery by the Purchaser of this Agreement and the fulfillment of and compliance with the terms hereof by the Purchaser does not
      and shall not as of each Closing Date (a) conflict with or result in a breach by the Purchaser of the terms, conditions or provisions of, (b) constitute a default under, (c) result in the creation of any lien, security interest, charge or encumbrance
      upon the Purchaser’s equity or assets under, (d) result in a violation of, or (e) require any authorization, consent, approval, exemption or other action by or notice or declaration to, or filing with, any court or administrative or governmental body
      or agency pursuant to the Purchaser’s organizational documents in effect on the date hereof or as may be amended prior to completion of the contemplated Public Offering, or any material law, statute, rule or regulation to which the Purchaser is
      subject, or any agreement, instrument, order, judgment or decree to which the Purchaser is subject, except for any filings required after the date hereof under federal or state securities laws.

    

    

    C. Investment Representations.

    

    

    (i) The Purchaser is acquiring the Private Placement Warrants and, upon exercise of the Private Placement Warrants, the Shares issuable upon such exercise
      (collectively, the “Securities”) for its own account, for investment purposes only and not with a view towards, or for resale in connection with, any public sale or distribution thereof.

    

    

    
      

      
        

      

    

    (ii) The Purchaser is an “accredited investor” as such term is defined in Rule 501(a)(3) of Regulation D, and the Purchaser has not experienced a
      disqualifying event as enumerated pursuant to Rule 506(d) of Regulation D under the Securities Act.

    

    

    (iii) The Purchaser understands that the Securities are being offered and will be sold to it in reliance on specific exemptions from the registration
      requirements of the United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and the Purchaser’s compliance with, the representations and warranties of the Purchaser set forth herein in order to
      determine the availability of such exemptions and the eligibility of the Purchaser to acquire such Securities.

    

    

    (iv) The Purchaser did not decide to enter into this Agreement as a result of any general solicitation or general advertising within the meaning of Rule
      502(c) under the Securities Act.

    

    

    (v) The Purchaser has been furnished with all materials relating to the business, finances and operations of the Company and materials relating to the
      offer and sale of the Securities which have been requested by the Purchaser. The Purchaser has been afforded the opportunity to ask questions of the executive officers and directors of the Company. The Purchaser understands that its investment in the
      Securities involves a high degree of risk and it has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to the acquisition of the Securities.

    

    

    (vi) The Purchaser understands that no United States federal or state agency or any other government or governmental agency has passed on or made any
      recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities by the Purchaser nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

    

    

    (vii) The Purchaser understands that: (a) the Securities have not been and are not being registered under the Securities Act or any state securities laws,
      and may not be offered for sale, sold, assigned or transferred unless (1) subsequently registered thereunder or (2) sold in reliance on an exemption therefrom; and (b) except as specifically set forth in the Registration and Stockholder Rights
      Agreement, neither the Company nor any other person is under any obligation to register the Securities under the Securities Act or any state securities laws or to comply with the terms and conditions of any exemption thereunder. In this regard, the
      Purchaser understands that the SEC has taken the position that promoters or affiliates of a blank check company and their transferees, both before and after an initial business combination, are deemed to be “underwriters” under the Securities Act
      when reselling the securities of a blank check company. Based on that position, Rule 144 adopted pursuant to the Securities Act would not be available for resale transactions of the Securities despite technical compliance with the requirements of
      such Rule, and the Securities can be resold only through a registered offering or in reliance upon another exemption from the registration requirements of the Securities Act.

    

    

    (viii) The Purchaser has such knowledge and experience in financial and business matters, knowledge of the high degree of risk associated with investments
      in the securities of companies in the development stage such as the Company, is capable of evaluating the merits and risks of an investment in the Securities and is able to bear the economic risk of an investment in the Securities in the amount
      contemplated hereunder for an indefinite period of time. The Purchaser has adequate means of providing for its current financial needs and contingencies and will have no current or anticipated future needs for liquidity which would be jeopardized by
      the investment in the Securities. The Purchaser can afford a complete loss of its investments in the Securities.

    

    

    
      

      
        

      

    

    Section 4. Conditions of the Purchaser’s Obligations.

    

    

    The obligations of the Purchaser to purchase and pay for the Private Placement Warrants are subject to the fulfillment, on or before each Closing Date, of each of the
      following conditions:

    

    

    A. Representations and Warranties. The representations and warranties of the Company contained in Section 2 shall be true and correct at and as of
      such Closing Date as though then made.

    

    

    B. Performance. The Company shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are
      required to be performed or complied with by it on or before such Closing Date.

    

    

    C. No Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
      promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions
      contemplated by this Agreement or the Warrant Agreement.

    

    

    D. Warrant Agreement and Registration and Stockholder Rights Agreement. The Company shall have entered into the Warrant Agreement and the
      Registration and Stockholder Rights Agreement, in each case on terms satisfactory to the Purchaser.

    

    

    Section 5. Conditions of the Company’s Obligations.

    

    

    The obligations of the Company to the Purchaser under this Agreement are subject to the fulfillment, on or before each Closing Date, of each of the following conditions:

    

    

    A. Representations and Warranties. The representations and warranties of the Purchaser contained in Section 3 shall be true and correct at and as
      of such Closing Date as though then made.

    

    

    B. Performance. The Purchaser shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that
      are required to be performed or complied with by the Purchaser on or before such Closing Date.

    

    

    C. Corporate Consents. The Company shall have obtained the consent of its Board of Directors authorizing the execution, delivery and performance of
      this Agreement and the Warrant Agreement and the issuance and sale of the Private Placement Warrants hereunder.

    

    

    D. No Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
      promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions
      contemplated by this Agreement or the Warrant Agreement.

    

    

    E. Warrant Agreement and Registration and Stockholder Rights Agreement. The Company shall have entered into the Warrant Agreement and the
      Registration and Stockholder Rights Agreement, in each case on terms satisfactory to the Company.

    

    

    Section 6. Termination.

    

    

    This Agreement may be terminated by the Company or the Purchaser at any time after March 31, 2021 upon written notice to the other party hereto if the closing of the Public
      Offering does not occur prior to such date.

    

    

    Section 7. Survival of Representations and Warranties.

    

    

    All of the representations and warranties contained herein shall survive each Closing Date.

    

    

    
      

      
        

      

    

    Section 8. Definitions.

    

    

    Terms used but not otherwise defined in this Agreement shall have the meaning assigned to such terms in the Registration Statement.

    

    

    Section 9. Miscellaneous.

    

    

    A. Successors and Assigns. Except as otherwise expressly provided herein, all covenants and agreements contained in this Agreement by or on behalf
      of any of the parties hereto shall bind and inure to the benefit of the respective successors of the parties hereto whether so expressed or not. Notwithstanding the foregoing or anything to the contrary herein, the parties may not assign this
      Agreement, other than assignments by the Purchaser to affiliates thereof (including, without limitation one or more of its members).

    

    

    B. Severability. Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under
      applicable law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of this
      Agreement.

    

    

    C. Counterparts. This Agreement may be executed simultaneously in two or more counterparts, none of which need contain the signatures of more than
      one party, but all such counterparts taken together shall constitute one and the same agreement. A signed copy of this Agreement delivered by facsimile, e-mail or other means of electronic transmission shall be deemed to have the same legal effect as
      delivery of an original signed copy of this Agreement.

    

    

    D. Descriptive Headings; Interpretation. The descriptive headings of this Agreement are inserted for convenience only and do not constitute a
      substantive part of this Agreement. The use of the word “including” in this Agreement shall be by way of example rather than by limitation.

    

    

    E. Governing Law. This Agreement shall be deemed to be a contract made under the laws of the State of New York and for all purposes shall be
      construed in accordance with the internal laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the laws of another jurisdiction.

    

    

    F. Amendments. This Agreement may not be amended, modified or waived as to any particular provision, except by a written instrument executed by all
      parties hereto.

    

    

    [Signature page follows]

    

    

    
      

      
        

      

    

    IN WITNESS WHEREOF, the parties hereto have executed this Agreement to be effective as of the date first set forth above.

    

    

    	 	
            COMPANY:

          
	 	 	 
	 	
            HEALTHCARE SERVICES ACQUISITION CORPORATION

          
	 	 
	 	
            By:

          	
            /s/ Joshua B. Lynn

          
	 	
            Name:

          	
            Joshua B. Lynn

          
	 	
            Title:

          	
            Chief Financial Officer

          
	 	 	 
	 	
            PURCHASER:

          
	 	 
	 	
            HEALTHCARE SERVICES ACQUISITION HOLDINGS LLC

          
	 	 
	 	
            By:

          	
            /s/ Tao Tan

          
	 	
            Name:

          	
            Tao Tan

          
	 	
            Title:

          	
            Chief Operating Officer

          

    

    

    [Signature Page to Warrant Purchase Agreement]Exhibit 10.2

    

    

    INVESTMENT MANAGEMENT TRUST AGREEMENT

    

    

    This Investment Management Trust Agreement (this “Agreement”) is made effective as of December 22, 2020, by and between Healthcare Services Acquisition Corporation, a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York limited purpose trust company (the “Trustee”).

    

    

    WHEREAS, the Company’s registration statement on Form S-1, File No. 333-249389 ( the “Registration Statement”) and prospectus (the “Prospectus”)
      for the initial public offering of the Company’s units (the “Units”), each of which consists of one share of the Company’s
      Class A common stock, par value $0.0001 per share (the “Common Stock”), and a fraction of one redeemable warrant, each whole
      warrant entitling the holder thereof to purchase one share of Common Stock (such initial public offering hereinafter referred to as the “Offering”), has been declared effective as of the date hereof by the U.S. Securities and Exchange Commission;

    

    

    WHEREAS, the Company has entered into an Underwriting Agreement (the “Underwriting Agreement”) with B. Riley Securities, Inc. as underwriter (the “Underwriter”);

    

    

    WHEREAS, as described in the Prospectus, $288,000,000 of the proceeds of the Offering and sale of the Private Placement Warrants (as
      defined in the Underwriting Agreement) (or $331,200,000, if the Underwriter’s over-allotment option is exercised in full) will be delivered to the Trustee to be deposited and held in a segregated trust account located at all times in the United
      States (the “Trust Account”) for the benefit of the Company and the holders of the Common Stock included in the Units issued in
      the Offering as hereinafter provided (the amount to be delivered to the Trustee (and any interest subsequently earned thereon) is referred to herein as the “Property,” the stockholders for whose benefit the Trustee shall hold the Property will be referred to as the “Public Stockholders,” and the Public Stockholders and the Company will be referred to together as the “Beneficiaries”);

    

    

    WHEREAS, pursuant to the Underwriting Agreement, a portion of the Property equal to $10,080,000, or $11,592,000 if the Underwriter’s
      over-allotment option is exercised in full, is attributable to deferred underwriting discounts and commissions that will be payable by the Company to the Underwriter upon and concurrently with the consummation of the Business Combination (as defined
      below) (the “Deferred Discount”); and

    

    

    WHEREAS, the Company and the Trustee desire to enter into this Agreement to set forth the terms and conditions pursuant to which the
      Trustee shall hold the Property.

    

    

    NOW THEREFORE, IT IS AGREED:

    

    

    1. Agreements and Covenants of Trustee. The
      Trustee hereby agrees and covenants to:

    

    

    (a) Hold the Property in trust for the Beneficiaries in accordance with the terms of this Agreement in the Trust Account established by the
      Trustee in the United States at J.P. Morgan Chase Bank, N.A., (or at another U.S.-chartered commercial bank with consolidated assets of $100 billion or more) in the United States, maintained by the Trustee and at a brokerage institution selected by
      the Trustee that is reasonably satisfactory to the Company;

    

    

    (b) Manage, supervise and administer the Trust Account subject to the terms and conditions set forth herein;

    

    

    (c) In a timely manner, upon the written instruction of the Company, invest and reinvest the Property solely in United States government
      securities within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, having a maturity of 185 days or less, or in money market funds meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7
      promulgated under the Investment Company Act of 1940, as amended (or any successor rule), which invest only in direct U.S. government treasury obligations, as determined by the Company; it being understood that the Trust Account will earn no interest
      while account funds are uninvested awaiting the Company’s instructions hereunder and the Trustee may earn bank credits or other consideration;

    

    

    (d) Collect and receive, when due, all principal, interest or other income arising from the Property, which shall become part of the “Property,” as such term is used herein;

    

    

    
      

      
        

      

    

    (e) Promptly notify the Company and the Underwriter of all communications received by the Trustee with respect to any Property requiring
      action by the Company;

    

    

    (f) Supply any necessary information or documents as may be requested by the Company (or its authorized agents) in connection with the
      Company’s preparation of the tax returns relating to assets held in the Trust Account;

    

    

    (g) Participate in any plan or proceeding for protecting or enforcing any right or interest arising from the Property if, as and when
      instructed by the Company to do so;

    

    

    (h) Render to the Company monthly written statements of the activities of, and amounts in, the Trust Account reflecting all receipts and
      disbursements of the Trust Account;

    

    

    (i) Commence liquidation of the Trust Account only after and promptly after (x) receipt of, and only in accordance with, the terms of a
      letter from the Company (“Termination Letter”) in a form substantially similar to that attached hereto as either Exhibit A or Exhibit B, as applicable, signed on behalf of the Company
      by its Chief Executive Officer, Chief Financial Officer, President, Chief Operating Officer, Executive Vice President, Vice President, Secretary or Chairman of the board of directors of the Company (the “Board”) or other authorized officer of the Company, and complete the liquidation of the Trust Account and distribute the Property in the Trust Account, including
      interest not previously released to the Company to pay its franchise and income taxes (less up to $100,000 of interest that may be released to the Company to pay dissolution expenses), only as directed in the Termination Letter and the other
      documents referred to therein, or (y) upon the date which is the later of (1) 24 months after the closing of the Offering and (2) such later date as may be approved by the Company’s stockholders in accordance with the Company’s amended and restated
      certificate of incorporation if a Termination Letter has not been received by the Trustee prior to such date, in which case the Trust Account shall be liquidated in accordance with the procedures set forth in the Termination Letter attached as Exhibit B and the Property in the Trust Account, including interest not previously released to the Company to pay its franchise and income taxes (less up to
      $100,000 of interest that may be released to the Company to pay dissolution expenses) shall be distributed to the Public Stockholders of record as of such date;

    

    

    (j) Upon written request from the Company, which may be given from time to time in a form substantially similar to that attached hereto as
      Exhibit C, withdraw from the Trust Account and distribute to the Company the amount of interest earned on the Property requested by the Company to cover any
      tax obligation, including any franchise tax obligations, owed by the Company as a result of assets of the Company or interest or other income earned on the Property, which amount shall be delivered directly to the Company by electronic funds transfer
      or other method of prompt payment, and the Company shall forward such payment to the relevant taxing authority, as applicable; provided, however, that to the extent there is not sufficient cash in the Trust Account to pay such tax obligation, the
      Trustee shall liquidate such assets held in the Trust Account as shall be designated by the Company in writing to make such distribution, so long as there is no reduction in the principal amount per share initially deposited in the Trust Account;
      provided, further, that if the tax to be paid is a franchise tax, the written request by the Company to make such distribution shall be accompanied by a copy of the franchise tax bill from the State of Delaware for the Company (it being acknowledged
      and agreed that any such amount in excess of interest income earned on the Property shall not be payable from the Trust Account). The written request of the Company referenced above shall constitute presumptive evidence that the Company is entitled
      to said funds, and the Trustee shall have no responsibility to look beyond said request;

    

    

    (k) Upon written request from the Company, which may be given from time to time in a form substantially similar to that attached hereto as
      Exhibit D, the Trustee shall distribute on behalf of the Company the amount requested by the Company to be used to redeem shares of Common Stock from Public
      Stockholders properly submitted in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation to (i) modify the substance or timing of the Company’s obligation to allow redemption in
      connection with a Business Combination or to redeem 100% of the shares of Common Stock included in the Units sold in the Offering if the Company does not complete a Business Combination within the time period set forth in the Company’s amended and
      restated certificate of incorporation or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity; and

    

    

    
      

      
        

      

    

    (l) Not make any withdrawals or distributions from the Trust Account other than pursuant to Section 1(i), (j) or (k)
      above.

    

    

    2. Agreements and Covenants of the Company. The
      Company hereby agrees and covenants to:

    

    

    (a) Give all instructions to the Trustee hereunder in writing, signed by the Company’s Chairman of the Board, Chief Executive Officer,
      Chief Financial Officer, President, Chief Operating Officer, Executive Vice President, Vice President or Secretary. In addition, except with respect to its duties under Sections
          1(i), (j) and (k) hereof, the Trustee shall be
      entitled to rely on, and shall be protected in relying on, any verbal or telephonic advice or instruction which it, in good faith and with reasonable care, believes to be given by any one of the persons authorized above to give written instructions,
      provided that the Company shall promptly confirm such instructions in writing;

    

    

    (b) Subject to Section 4 hereof, hold the
      Trustee harmless and indemnify the Trustee from and against any and all expenses, including reasonable counsel fees and disbursements, or losses suffered by the Trustee in connection with any action taken by it hereunder and in connection with any
      action, suit or other proceeding brought against the Trustee involving any claim, or in connection with any claim or demand, which in any way arises out of or relates to this Agreement, the services of the Trustee hereunder, or the Property or any
      interest earned on the Property, except for expenses and losses resulting from the Trustee’s gross negligence, fraud or willful misconduct. Promptly after the receipt by the Trustee of notice of demand or claim or the commencement of any action, suit
      or proceeding, pursuant to which the Trustee intends to seek indemnification under this Section 2(b), it shall notify the Company in writing of such claim
      (hereinafter referred to as the “Indemnified Claim”). The Trustee shall have the right to conduct and manage the defense
      against such Indemnified Claim; provided that the Trustee shall obtain the consent of the Company with respect to the selection of counsel, which consent shall not be unreasonably withheld. The Trustee may not agree to settle any Indemnified Claim
      without the prior written consent of the Company, which such consent shall not be unreasonably withheld. The Company may participate in such action with its own counsel;

    

    

    (c) Pay the Trustee the fees set forth on Schedule A
      hereto, including an initial acceptance fee, annual administration fee, and transaction processing fee which fees shall be subject to modification by the parties from time to time. It is expressly understood that the Property shall not be used to pay
      such fees unless and until the closing of the Business Combination (defined below). The Company shall pay the Trustee the initial acceptance fee and the first annual administration fee at the consummation of the Offering. The Company shall not be
      responsible for any other fees or charges of the Trustee except as set forth in this Section 2(c), Schedule A and as may be provided in Section 2(b) hereof;

    

    

    (d) In connection with any vote of the Company’s stockholders regarding a merger, capital stock exchange, asset acquisition, stock
      purchase, reorganization or similar business combination involving the Company and one or more businesses (the “Business Combination”),
      provide to the Trustee an affidavit or certificate of the inspector of elections for the stockholder meeting verifying the vote of such stockholders regarding such Business Combination;

    

    

    (e) Provide the Underwriter with a copy of any Termination Letter(s) and/or any other correspondence that is sent to the Trustee with
      respect to any proposed withdrawal from the Trust Account promptly after it issues the same;

    

    

    (f) Unless otherwise agreed between the Company and the Underwriter, ensure that any Instruction Letter (as defined in Exhibit A) delivered in connection with a Termination Letter in the form of Exhibit
          A expressly provides that the Deferred Discount is paid directly to the account or accounts directed by the Underwriter prior to any transfer of the funds held in the Trust Account to the Company or any other person;

    

    

    (g) Instruct the Trustee to make only those distributions that are permitted under this Agreement, and refrain from instructing the Trustee
      to make any distributions that are not permitted under this Agreement; and

    

    

    (h) Within five (5) business days after the Underwriter exercises the over-allotment option (or any unexercised portion thereof) or such
      over-allotment option expires, provide the Trustee with a notice in writing of the total amount of the Deferred Discount, which shall in no event be less than $10,080,000.

    

    

    
      

      
        

      

    

    3. Limitations of Liability. The Trustee shall
      have no responsibility or liability to:

    

    

    (a) Imply obligations, perform duties, inquire or otherwise be subject to the provisions of any agreement or document other than this
      Agreement and that which is expressly set forth herein;

    

    

    (b) Take any action with respect to the Property, other than as directed in Section 1 hereof, and the Trustee shall have no liability to any third party except for liability arising out of the Trustee’s gross negligence, fraud or willful misconduct;

    

    

    (c) Institute any proceeding for the collection of any principal and income arising from, or institute, appear in or defend any proceeding
      of any kind with respect to, any of the Property unless and until it shall have received instructions from the Company given as provided herein to do so and the Company shall have advanced or guaranteed to it funds sufficient to pay any expenses
      incident thereto;

    

    

    (d) Refund any depreciation in principal of any Property;

    

    

    (e) Assume that the authority of any person designated by the Company to give instructions hereunder shall not be continuing unless
      provided otherwise in such designation, or unless the Company shall have delivered a written revocation of such authority to the Trustee;

    

    

    (f) The other parties hereto or to anyone else for any action taken or omitted by it, or any action suffered by it to be taken or omitted,
      in good faith and in the Trustee’s best judgment, except for the Trustee’s gross negligence, fraud or willful misconduct. The Trustee may rely conclusively and shall be protected in acting upon any order, notice, demand, certificate, opinion or
      advice of counsel (including counsel chosen by the Trustee, which counsel may be the Company’s counsel), statement, instrument, report or other paper or document (not only as to its due execution and the validity and effectiveness of its provisions,
      but also as to the truth and acceptability of any information therein contained) which the Trustee believes, in good faith and with reasonable care, to be genuine and to be signed or presented by the proper person or persons. The Trustee shall not be
      bound by any notice or demand, or any waiver, modification, termination or rescission of this Agreement or any of the terms hereof, unless evidenced by a written instrument delivered to the Trustee, signed by the proper party or parties and, if the
      duties or rights of the Trustee are affected, unless it shall give its prior written consent thereto;

    

    

    (g) Verify the accuracy of the information contained in the Registration Statement;

    

    

    (h) Provide any assurance that any Business Combination entered into by the Company or any other action taken by the Company is as
      contemplated by the Registration Statement;

    

    

    (i) File information returns with respect to the Trust Account with any local, state or federal taxing authority or provide periodic
      written statements to the Company documenting the taxes payable by the Company, if any, relating to any interest income earned on the Property;

    

    

    (j) Prepare, execute and file tax reports, income or other tax returns and pay any taxes with respect to any income generated by, and
      activities relating to, the Trust Account, regardless of whether such tax is payable by the Trust Account or the Company, including, but not limited to, franchise and income tax obligations, except pursuant to Section 1(j) hereof; or

    

    

    (k) Verify calculations, qualify or otherwise approve the Company’s written requests for distributions pursuant to Sections 1(i), (j) or (k) hereof.

    

    

    4. Trust Account Waiver. The Trustee has no
      right of set-off or any right, title, interest or claim of any kind (“Claim”) to, or to any monies in, the Trust Account, and
      hereby irrevocably waives any Claim to, or to any monies in, the Trust Account that it may have now or in the future. In the event the Trustee has any Claim against the Company under this Agreement, including, without limitation, under Section 2(b) or Section 2(c) hereof, the Trustee shall pursue such
      Claim solely against the Company and its assets outside the Trust Account and not against the Property or any monies in the Trust Account.

    

    

    
      

      
        

      

    

    5. Termination. This Agreement shall terminate
      as follows:

    

    

    (a) If the Trustee gives written notice to the Company that it desires to resign under this Agreement, the Company shall use its reasonable
      efforts to locate a successor trustee, pending which the Trustee shall continue to act in accordance with this Agreement. At such time that the Company notifies the Trustee that a successor trustee has been appointed by the Company and has agreed to
      become subject to the terms of this Agreement, the Trustee shall transfer the management of the Trust Account to the successor trustee, including but not limited to the transfer of copies of the reports and statements relating to the Trust Account,
      whereupon this Agreement shall terminate; provided, however, that in the event that the Company does not locate a successor trustee within ninety (90) days of receipt of the resignation notice from the Trustee, the Trustee may submit an application
      to have the Property deposited with any court in the State of New York or with the United States District Court for the Southern District of New York and upon such deposit, the Trustee shall be immune from any liability whatsoever; or

    

    

    (b) At such time that the Trustee has completed the liquidation of the Trust Account and its obligations in accordance with the provisions
      of Section 1(i) hereof (which section may not be amended under any circumstances) and distributed the Property in accordance with the provisions of the
      Termination Letter, this Agreement shall terminate except with respect to Section 2(b) and Section 4.

    

    

    6. Miscellaneous.

    

    

    (a) The Company and the Trustee each acknowledge that the Trustee will follow the security procedures set forth below with respect to funds
      transferred from the Trust Account. The Company and the Trustee will each restrict access to confidential information relating to such security procedures to authorized persons. Each party must notify the other party immediately if it has reason to
      believe unauthorized persons may have obtained access to such confidential information, or of any change in its authorized personnel. In executing funds transfers, the Trustee shall rely upon all information supplied to it by the Company, including,
      account names, account numbers, and all other identifying information relating to a Beneficiary, Beneficiary’s bank or intermediary bank. Except for any liability arising out of the Trustee’s gross negligence, fraud or willful misconduct, the Trustee
      shall not be liable for any loss, liability or expense resulting from any error in the information or transmission of the funds.

    

    

    (b) This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without giving
      effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. This Agreement may be executed in several original or facsimile counterparts, each one of which shall constitute an original,
      and together shall constitute but one instrument.

    

    

    (c) This Agreement contains the entire agreement and understanding of the parties hereto with respect to the subject matter hereof. This
      Agreement or any provision hereof may only be changed, amended or modified (other than to correct a typographical error) by a writing signed by each of the parties hereto.

    

    

    (d) This Agreement or any provision hereof may only be changed, amended or modified pursuant to Section 6(c) hereof with the Consent of the Stockholders. For purposes of this Section 6(d), the “Consent of the Stockholders” means (i) receipt by the Trustee of a certificate from the inspector of elections of the stockholder
      meeting certifying that the Company’s stockholders of record as of a record date established in accordance with Section 213(a) of the Delaware General Corporation Law, as amended (or any successor rule), who hold sixty-five percent (65%) or more of
      all then outstanding shares of the Common Stock and Class B common stock, par value $0.0001 per share, of the Company voting together as a single class, have voted in favor of such change, amendment or modification, or (ii) the Company’s stockholders
      of record as of the record date who hold sixty-five percent (65%) or more of all then outstanding shares of the Common Stock and Class B common stock, par value $0.0001 per share, of the Company voting together as a single class, have delivered to
      the Trustee a signed writing approving such change, amendment or modification. No such amendment will affect any Public Stockholder who has otherwise indicated his, her or its election to redeem his, her or its shares of Common Stock in connection
      with a stockholder vote sought to amend this Agreement, including a corresponding change to the Company’s amended and restated certificate of incorporation. Except for any liability arising out of the Trustee’s gross negligence, fraud or willful
      misconduct, the Trustee may rely conclusively on the certification from the inspector or elections referenced above and shall be relieved of all liability to any party for executing the proposed amendment in reliance thereon.

    

    

    
      

      
        

      

    

    (e) The parties hereto consent to the jurisdiction and venue of any state or federal court located in the City of New York, State of New
      York, for purposes of resolving any disputes hereunder. AS TO ANY CLAIM, CROSS-CLAIM OR COUNTERCLAIM IN ANY WAY RELATING TO THIS AGREEMENT, EACH PARTY WAIVES THE RIGHT TO TRIAL BY JURY.

    

    

    (f) Any notice, consent or request to be given in connection with any of the terms or provisions of this Agreement shall be in writing and
      shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery or by electronic mail:

    

    

    if to the Trustee, to:

    

    

    Continental Stock Transfer & Trust Company

    1 State Street, 30th Floor

    New York, NY 10004

    Attn: Francis Wolf and Celeste Gonzalez

    Email: fwolf@continentalstock.com

    cgonzalez@continentalstock.com

    

    

    if to the Company, to:

    

    

    Healthcare Services Acquisition Corporation

    7809 Woodmont Avenue, Suite 200

    Bethesda, MD 20814

    Attn: Tao Tan

    Email: tao.tan@healthcarespac.com

    

    

    in each case, with copies, which shall not constitute notice, to:

    

    

    Ropes & Gray LLP

    1211 Avenue of the Americas

    New York, NY 10036

    Attention: Paul Tropp and Christopher Capuzzi

    Email: paul.tropp@ropesgray.com, christopher.capuzzi@ropesgray.com

    

    

    and

    

    

    B. Riley Securities, Inc.

    299 Park Avenue

    New York, New York 10171

    Attention:  Syndicate Department

    

    

    and

    

    

    Ellenoff Grossman & Schole LLP

    1345 Avenue of the Americas

    New York, New York 10105

    Attn: Stuart Neuhauser

    Email: sneuhauser@egsllp.com

    

    

    
      

      
        

      

    

    (g) Each of the Company and the Trustee hereby represents that it has the full right and power and has been duly authorized to enter into
      this Agreement and to perform its respective obligations as contemplated hereunder. The Trustee acknowledges and agrees that it shall not make any claims or proceed against the Trust Account, including by way of set-off, and shall not be entitled to
      any funds in the Trust Account under any circumstance.

    

    

    (h) This Agreement is the joint product of the Trustee and the Company and each provision hereof has been subject to the mutual
      consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.

    

    

    (i) This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all such
      counterparts shall together constitute one and the same instrument. Delivery of a signed counterpart of this Agreement by facsimile or electronic transmission shall constitute valid and sufficient delivery thereof.

    

    

    (j) Each of the Company and the Trustee hereby acknowledges and agrees that the Underwriter is a third party beneficiary of this Agreement.

    

    

    (k) Except as specified herein, no party to this Agreement may assign its rights or delegate its obligations hereunder to any other person
      or entity.

    

    

    [Signature Page Follows]

    

    

    
      

      
        

      

    

    IN WITNESS WHEREOF, the parties have
      duly executed this Investment Management Trust Agreement as of the date first written above.

    

    

    	 	
            CONTINENTAL STOCK TRANSFER &

            TRUST COMPANY, as Trustee

          
	 	 
	 	
            By:

          	
            /s/ Francis Wolf

          
	 	
            Name:

          	
             Francis Wolf

          
	 	
            Title:

          	
            Vice President

          
	 	 	 
	 	
            HEALTHCARE SERVICES ACQUISITION CORPORATION

          
	 	 
	 	
            By:

          	
            /s/ Tao Tan

          
	 	
            Name:

          	
             Tao Tan

          
	 	
            Title:

          	
            Chief Operating Officer

          

    

    

    
      

      
        

      

    

    SCHEDULE A

    

    

    	
            Fee Item

          	
            Time and method of payment

          	 	
            Amount

          	 
	
            Initial set-up fee

          	
            Initial closing of Offering by wire transfer

          	 	
            $

          	
            3,500.00

          	 
	
            Trustee administration fee

          	
            First year, initial closing of Offering by wire transfer, thereafter on the anniversary of the effective date of the Offering by wire transfer or
              check

          	 	
            $

          	
            10,000.00

          	 
	
            Transaction processing fee for disbursements to Company under Sections 1(i) and 1(j)

          	
            Billed to Company following disbursement made to Company under Section 1

          	 	
            $

          	
            250.00

          	 
	
            Paying Agent services as required pursuant to Sections 1(i) and 1(k)

          	
            Billed to Company upon delivery of service pursuant to Sections 1(i) and 1(k)

          	 	
            Prevailing rates

          	 

    

    

    
      

      
        

      

    

    EXHIBIT A

    

    

    [Letterhead of Company]

    

    

    [Insert date]

    

    

    Continental Stock Transfer & Trust Company

    1 State Street, 30th Floor

    New York, New York 10004

    Attn: Francis Wolf and Celeste Gonzalez

    

    

    Re: Trust Account - Termination Letter

    

    

    Ladies and Gentlemen:

    

    

    Pursuant to Section 1(i) of the Investment
      Management Trust Agreement between Healthcare Services Acquisition Corporation (the “Company”) and Continental Stock Transfer
      & Trust Company (the “Trustee”), dated as of _________, 2020 (the “Trust Agreement”), this is to advise you that the Company has entered into an agreement with __________ (the “Target Business”) to consummate a business combination with the Target Business (the “Business Combination”) on or about [insert date]. The Company shall notify you at least seventy-two (72) hours in advance (or such shorter time as you may agree) of the actual date of the consummation of the Business Combination
      (the “Consummation Date”). Capitalized terms used but not defined herein shall have the meanings set forth in the Trust
      Agreement.

    

    

    In accordance with the terms of the Trust Agreement, we hereby authorize you to commence to liquidate all of the assets of the Trust
      Account and transfer the proceeds to a segregated account held by you on behalf of the Beneficiaries to the effect that, on the Consummation Date, all of the funds held in the Trust Operating Account at JP Morgan Chase Bank, N.A. will be immediately
      available for transfer to the account or accounts that the Company shall direct on the Consummation Date (including as directed to it by the Underwriter (with respect to the Deferred Discount)). It is acknowledged and agreed that while the funds are
      on deposit in the trust operating account at J.P. Morgan Chase Bank, N.A. awaiting distribution, the Company will not earn any interest or dividends.

    

    

    On the Consummation Date (i) counsel for the Company shall deliver to you written notification that the Business Combination has been
      consummated, or will be consummated substantially concurrently with your transfer of funds to the accounts as directed by the Company (the “Notification”) and (ii) the Company shall deliver to you (a) a certificate of the Chief Executive Officer, Chief Financial Officer or other authorized officer of the Company, which verifies that the Business Combination has been
      approved by a vote of the Company’s stockholders, if a vote is held, and (b) a joint written instruction signed by the Company and the Underwriter with respect to the transfer of the funds held in the Trust Account, including payment of amounts owed
      to public stockholders who have properly exercised their redemption rights and payment of the Deferred Discount to the Underwriter from the Trust Account (the “Instruction Letter”). You are hereby directed and authorized to transfer the funds held in the Trust Account immediately upon your receipt of the Notification and the Instruction Letter, in accordance with the
      terms of the Instruction Letter. In the event that certain deposits held in the Trust Account may not be liquidated by the Consummation Date without penalty, you will notify the Company in writing of the same and the Company shall direct you as to
      whether such funds should remain in the Trust Account and be distributed after the Consummation Date to the Company. Upon the distribution of all the funds, net of any payments necessary for reasonable unreimbursed expenses related to liquidating the
      Trust Account, your obligations under the Trust Agreement shall be terminated.

    

    

    In the event that the Business Combination is not consummated on the Consummation Date described in the notice thereof and we have not
      notified you on or before the original Consummation Date of a new Consummation Date, then upon receipt by the Trustee of written instructions from the Company, the funds held in the Trust Account shall be reinvested as provided in Section 1(c) of the
      Trust Agreement on the business day immediately following the Consummation Date as set forth in such notice as soon thereafter as possible.

     

    

    	 	
            Very truly yours,

          
	 	
            Healthcare Services Acquisition Corporatio

          
	 	 
	 	 
	 	
            By:

          	 
	 	
            Name:

          	 
	 	
            Title:

          	 
	
            cc: B. Riley Securities, Inc.

          	 

    
      

      
        

      

    

    EXHIBIT B

    

    

    [Letterhead of Company]

    

    

    [Insert date]

    

    

    Continental Stock Transfer & Trust Company

    1 State Street, 30th Floor

    New York, New York 10004

    Attn: Francis Wolf and Celeste Gonzalez

    

    

    Re: Trust Account - Termination Letter

    

    

    Ladies and Gentlemen:

    

    

    Pursuant to Section 1(i) of the Investment Management Trust Agreement between Healthcare Services Acquisition Corporation (the “Company”) and Continental Stock Transfer & Trust Company (the “Trustee”), dated as of _________, 2020 (the “Trust Agreement”),
      this is to advise you that the Company did not effect a business combination with a Target Business (the “Business Combination”)
      within the time frame specified in the Company’s amended and restated certificate of incorporation, as described in the Company’s Prospectus relating to the Offering. Capitalized terms used but not defined herein shall have the meanings set forth in
      the Trust Agreement.

    

    

    In accordance with the terms of the Trust Agreement, we hereby authorize you to liquidate all of the assets in the Trust Account and
      transfer the total proceeds into a segregated account held by you on behalf of the Beneficiaries to await distribution to the Public Stockholders. The Company has selected [_________, 20__]1 as the effective date for the purpose of
      determining when the Public Stockholders will be entitled to receive their share of the liquidation proceeds. You agree to be the Paying Agent of record and, in your separate capacity as Paying Agent, agree to distribute said funds directly to the
      Company’s Public Stockholders in accordance with the terms of the Trust Agreement and the Company’s amended and restated certificate of incorporation. Upon the distribution of all the funds, net of any payments necessary for reasonable unreimbursed
      expenses related to liquidating the Trust Account, your obligations under the Trust Agreement shall be terminated, except to the extent otherwise provided in Section 1(i) of the Trust Agreement.

    

    

    

    

    	 	
            Very truly yours,

          
	 	 
	 	
            Healthcare Services Acquisition Corporation

          
	 	 
	 	
            By:

          	 
	 	
            Name:

          	 
	 	
            Title:

          	 
	
            cc:  B. Riley Securities, Inc.

          	 

    

    

    

    

    

    1 24 months from the closing of the Offering or at a later date, if extended.

    
      

      
        

      

    

    EXHIBIT C

    

    

    [Letterhead of Company]

    

    

    [Insert date]

    

    

    Continental Stock Transfer & Trust Company

    1 State Street, 30th Floor

    New York, New York 10004

    Attn: Francis Wolf and Celeste Gonzalez

    

    

    Re: Trust Account - Withdrawal Instruction

    

    

    Ladies and Gentlemen:

    

    

    Pursuant to Section 1(j) of the Investment Management Trust Agreement between Healthcare Services Acquisition Corporation (the “Company”) and Continental Stock Transfer & Trust Company (the “Trustee”), dated as of _________, 2020 (the “Trust Agreement”),
      the Company hereby requests that you deliver to the Company $_____ of the interest income earned on the Property as of the date hereof. Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement.

    

    

    The Company needs such funds to pay for the tax obligations as set forth on the attached tax return or tax statement. In accordance with
      the terms of the Trust Agreement, you are hereby directed and authorized to transfer (via wire transfer) such funds promptly upon your receipt of this letter to the Company’s operating account at:

    

    

    [WIRE INSTRUCTION INFORMATION]

    

    

    	 	
            Very truly yours,

          
	 	 
	 	
            Healthcare Services Acquisition Corporation

          
	 	 
	 	
            By:

          	 
	 	
            Name:

          	 
	 	
            Title:

          	 
	
            cc: B. Riley Securities, Inc.

          	 
	 	 
	 	 

    
      

      
        

      

    

    EXHIBIT D

    

    

    [Letterhead of Company]

    

    

    [Insert date]

    

    

    Continental Stock Transfer & Trust Company

    1 State Street, 30th Floor

    New York, New York 10004

    Attn: Francis Wolf and Celeste Gonzalez

    

    

    Re: Trust Account - Stockholder Redemption Withdrawal
          Instruction

    

    

    Ladies and Gentlemen:

    

    

    Pursuant to Section 1(k) of the Investment Management Trust Agreement between Healthcare Services Acquisition Corporation (the “Company”) and Continental Stock Transfer & Trust Company (the “Trustee”), dated as of _________, 2020 (the “Trust Agreement”),
      the Company hereby requests that you deliver to the redeeming Public Stockholders of the Company $_____ of the principal and interest income earned on the Property as of the date hereof to a segregated account held by you on behalf of the
      Beneficiaries for distribution to the Public Stockholders who have requested redemption of their shares of Common Stock. Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement.

    

    

    The Company needs such funds to pay its Public Stockholders who have properly elected to have their shares of Common Stock redeemed by the
      Company in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation to (i) modify the substance or timing of the Company’s obligation to allow redemption in connection with a
      Business Combination or to redeem 100% of the shares of Common Stock included in the Units sold in the Offering if the Company does not complete a Business Combination within the time period set forth in the Company’s amended and restated certificate
      of incorporation or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity. As such, you are hereby directed and authorized to transfer (via wire transfer) such funds promptly upon your
      receipt of this letter.

    

    

    	 	
            Very truly yours,

          
	 	
            Healthcare Services Acquisition Corporation

          
	 	 
	 	
            By:

          	 
	 	
            Name:

          	 
	 	
            Title:

          	 
	
            cc: B. Riley Securities, Inc.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00318-of-00352.parquet"}]]